Angela LaRosa

Concepts (112)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Down Syndrome
8
2020
120
1.890
Why?
Central Nervous System Stimulants
5
2022
221
1.180
Why?
Attention Deficit Disorder with Hyperactivity
4
2022
189
1.080
Why?
Autism Spectrum Disorder
3
2022
111
0.910
Why?
Attention Deficit and Disruptive Behavior Disorders
1
2019
29
0.680
Why?
Adrenergic alpha-Agonists
1
2019
57
0.680
Why?
Anemia, Iron-Deficiency
1
2020
34
0.680
Why?
Treatment Refusal
1
2019
40
0.660
Why?
Child, Preschool
13
2022
3187
0.620
Why?
Intellectual Disability
1
2019
114
0.610
Why?
Practice Guidelines as Topic
1
2020
772
0.490
Why?
Sleep Apnea Syndromes
1
2015
40
0.480
Why?
Sleep Apnea, Obstructive
4
2017
142
0.480
Why?
Developmental Disabilities
2
2012
119
0.480
Why?
Tonsillectomy
4
2017
69
0.440
Why?
Methylphenidate
3
2021
97
0.430
Why?
Child Behavior Disorders
1
2012
69
0.410
Why?
Parents
2
2019
312
0.400
Why?
Mass Screening
3
2012
843
0.390
Why?
Child
12
2022
6405
0.350
Why?
Adenoidectomy
3
2017
51
0.320
Why?
Child Development
1
2009
102
0.320
Why?
Parenting
1
2009
91
0.310
Why?
Exosomes
2
2019
44
0.300
Why?
Adolescent
10
2020
8912
0.270
Why?
Health Status
1
2009
429
0.270
Why?
Infant
6
2020
2891
0.250
Why?
Cross-Sectional Studies
3
2019
2279
0.240
Why?
Comorbidity
2
2020
1426
0.220
Why?
Retrospective Studies
5
2022
7277
0.200
Why?
Depression
1
2009
943
0.200
Why?
Humans
18
2022
68618
0.200
Why?
Guanfacine
1
2021
6
0.190
Why?
Adrenergic alpha-2 Receptor Agonists
1
2021
11
0.190
Why?
Sleep Wake Disorders
1
2022
94
0.190
Why?
Male
12
2021
37321
0.190
Why?
Female
12
2021
38074
0.190
Why?
Electronic Health Records
2
2021
374
0.170
Why?
Protective Devices
1
2019
13
0.170
Why?
Extracellular Vesicles
1
2019
21
0.170
Why?
Amphetamine
1
2019
77
0.170
Why?
Communication Disorders
1
2019
12
0.170
Why?
Endocytosis
1
2019
113
0.160
Why?
Insurance, Health
1
2019
201
0.150
Why?
Societies, Medical
1
2020
403
0.150
Why?
Medicaid
1
2019
302
0.140
Why?
Pediatrics
1
2020
341
0.140
Why?
Weight Gain
1
2017
135
0.140
Why?
Schools
2
2021
156
0.130
Why?
Sleep Apnea, Central
1
2015
6
0.130
Why?
Hypoventilation
1
2015
8
0.130
Why?
Facial Bones
1
2015
10
0.130
Why?
Practice Patterns, Physicians'
1
2019
504
0.120
Why?
Age Factors
1
2019
1864
0.120
Why?
Pharynx
1
2015
89
0.120
Why?
South Carolina
1
2020
2752
0.110
Why?
Risk Assessment
1
2019
2007
0.110
Why?
Early Diagnosis
1
2012
122
0.100
Why?
Physicians, Primary Care
1
2012
46
0.100
Why?
Cognition Disorders
1
2015
342
0.100
Why?
United States
3
2019
7367
0.100
Why?
Alzheimer Disease
1
2016
565
0.100
Why?
Attention
1
2012
225
0.090
Why?
Psychometrics
1
2012
514
0.090
Why?
Evidence-Based Practice
1
2011
146
0.080
Why?
Residence Characteristics
1
2011
252
0.080
Why?
Parent-Child Relations
1
2009
98
0.080
Why?
Infant, Newborn
2
2017
2455
0.080
Why?
Anemia, Sickle Cell
1
2012
364
0.080
Why?
Obesity
1
2015
1076
0.070
Why?
Health Promotion
1
2011
407
0.070
Why?
Psychiatric Status Rating Scales
1
2009
782
0.070
Why?
Postoperative Period
2
2017
238
0.070
Why?
Young Adult
4
2017
5717
0.070
Why?
Logistic Models
1
2009
1420
0.060
Why?
Irritable Mood
1
2021
15
0.050
Why?
Medication Therapy Management
1
2021
32
0.050
Why?
Disorders of Excessive Somnolence
1
2021
28
0.050
Why?
Telephone
1
2021
160
0.050
Why?
Educational Status
1
2021
273
0.050
Why?
Adult
2
2017
21403
0.040
Why?
Feeding and Eating Disorders
1
2021
106
0.040
Why?
Cell Communication
1
2019
116
0.040
Why?
Palate
1
2017
14
0.040
Why?
Tongue
1
2017
20
0.040
Why?
Tracheostomy
1
2017
31
0.040
Why?
Postoperative Hemorrhage
1
2017
69
0.040
Why?
Polysomnography
1
2017
92
0.030
Why?
tau Proteins
1
2016
61
0.030
Why?
Amyloid beta-Peptides
1
2016
191
0.030
Why?
Combined Modality Therapy
1
2017
951
0.030
Why?
Peptide Fragments
1
2016
483
0.030
Why?
Body Mass Index
1
2017
867
0.030
Why?
Treatment Outcome
2
2017
7029
0.030
Why?
Reaction Time
1
2012
170
0.020
Why?
Hospitalization
1
2017
978
0.020
Why?
Cohort Studies
1
2017
2358
0.020
Why?
Healthy People Programs
1
2011
13
0.020
Why?
Biomarkers
1
2016
1593
0.020
Why?
Fragile X Syndrome
1
2010
17
0.020
Why?
Smoking Prevention
1
2011
259
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
320
0.020
Why?
Middle Aged
2
2017
21147
0.020
Why?
Cognition
1
2012
513
0.020
Why?
Double-Blind Method
1
2012
1738
0.020
Why?
Pilot Projects
1
2012
1342
0.020
Why?
Wounds and Injuries
1
2011
334
0.020
Why?
Diet
1
2011
514
0.020
Why?
Exercise
1
2011
658
0.020
Why?
Animals
1
2019
20881
0.010
Why?
Substance-Related Disorders
1
2011
1242
0.010
Why?
Magnetic Resonance Imaging
1
2010
2223
0.010
Why?
LaRosa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (112)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_